Healed shingles blisters don't mean the pain is over. The damage the virus leaves behind in the nerve ganglion keeps generating pain signals within the nervous system even after the skin has recovered. This is the essence of postherpetic neuralgia (PHN). Understanding the mechanism accurately and starting staged treatment early can lower the risk of the condition becoming chronic.
PHN is diagnosed when pain persists in the same area for three months or more after the blisters appear (Lim Delwyn Zhi Jie et al., 2025). The skin has already healed, but the pain remains on its own—that is PHN. Shingles itself results from reactivation of the varicella-zoster virus (VZV), and PHN is its most common complication (Patil Anant et al., 2022).
About 5–30% of shingles patients aged 50 or older progress to PHN (Patil Anant et al., 2022). The transition rate rises with age, and in patients in their 70s or older, pain can persist for months—or in some cases years—after the blisters have cleared.
PHN pain is not simple soreness. A burning sensation settles deep beneath the skin, and sharp, electric-shock-like jolts appear unpredictably. Allodynia is clinically one of the most distressing symptoms—a state in which even a shirt collar brushing the skin or a light breeze triggers severe pain, so that any ordinary contact can become a source of suffering.
Skin recovers relatively quickly through cell regeneration, but nerve damage follows an entirely different recovery path. As long as the structural damage to the nerve remains, the nervous system keeps sending faulty pain signals. In some cases the pain resolves on its own, but without appropriate treatment it can also persist as chronic pain for years.
Nerves Don't Heal Like Skin — How PHN Develops
After a bout of chickenpox, the varicella-zoster virus (VZV) never fully disappears. The virus lies dormant for decades in the dorsal root ganglia (clusters of sensory nerves that extend from the spinal cord toward the periphery) (Patil Anant et al., 2022). It stays silent as long as immunity remains strong, but aging, stress, or immunosuppression can trigger reactivation. Once reactivated, VZV travels from the ganglia along peripheral nerves, directly damaging nerve tissue (Patil Anant et al., 2022).
The problem is that this damage becomes imprinted on the nerve fibers themselves. Damaged C fibers and Aδ fibers (nerves that carry pain and temperature signals) start generating electrical signals on their own, even without any stimulus. This is called peripheral sensitization — much like a smoke detector malfunctioning and going off continuously when there's no fire. Even light touch or a change in temperature gets converted into a signal of severe pain (Finnerup Nanna Brix et al., 2021).
When peripheral sensitization persists, changes also occur at the spinal cord level. Neurons in the dorsal horn (the region at the back of the spinal cord that first receives sensory signals) become excessively excitable and start processing even normal stimuli as exaggerated pain. This is central sensitization (Finnerup Nanna Brix et al., 2021). Once central sensitization takes hold, the source of pain shifts from the peripheral nerves to the central nervous system itself.
These two sensitization mechanisms place PHN in an entirely different category from ordinary wound pain. Because the pain signal itself is distorted, standard painkillers alone often fail to adequately address this neuropathic pain. This is exactly why an approach that lowers nerve excitability or regulates the distorted signal transmission is needed.
Treatment Options — From Medication to Nerve Intervention Procedures
PHN treatment is less about eliminating pain immediately and more about creating an environment in which the nerves can recover. Because the pain signal itself is distorted, the goal of treatment is to regulate that distortion step by step. Treatment response and course can vary between individuals, and the specific treatment direction should be decided in consultation with a specialist.
Gabapentin and pregabalin, both gabapentinoids, are used preferentially as first-line drug therapy (Lim Delwyn Zhi Jie et al., 2025). Both drugs suppress nerve excitability and are involved in easing peripheral and central sensitization (Finnerup Nanna Brix et al., 2021). The tricyclic antidepressant amitriptyline has also been reported to help control pain in neuropathic pain (Lim Delwyn Zhi Jie et al., 2025). Lidocaine patches applied directly to the skin locally block peripheral nerve stimulation and are used as an adjunct in patients with severe allodynia.
Opioids are considered only in a limited way, when other treatments have not produced an adequate response. Given the risk of dependence and side effects with long-term use, they should be weighed carefully as part of combination therapy with other medications or alongside interventional procedures, rather than used alone as first-line treatment.
When medication alone does not adequately control pain, or when side effects become a problem, treatment moves on to nerve intervention procedures (Lim Delwyn Zhi Jie et al., 2025). Nerve block is a procedure that uses ultrasound or C-arm imaging to deliver a local anesthetic, alone or combined with a steroid, to the affected ganglion or the area around the nerve. It may help modulate the pathway through which pain signals travel to the central nervous system while reducing inflammation around the nerve.
In patients who respond only partially to medication, adding a nerve block alongside it may help with pain control. However, the effect and how long it lasts vary between individuals. Adjunct therapies such as transcutaneous electrical nerve stimulation (TENS) play a supplementary role in the pain-control process.
A stepwise approach does not simply mean escalating treatment intensity. The core of the treatment strategy is to regulate, at each stage, the process by which peripheral sensitization hardens into central sensitization — thereby reducing the risk that the pain becomes fixed into a chronic pattern.
When to Seek Care, and Which Specialty
In postherpetic neuralgia, timing can be a variable that affects prognosis. If pain persists for 4 weeks or more after the blisters clear, seeing a specialist before the pain becomes chronic may affect the course of the condition. The longer treatment is delayed, the deeper central sensitization tends to become, and once central sensitization has set in, it tends to respond less well to treatment (Lim Delwyn Zhi Jie et al., 2025).
You may want to consider specialist care if pain intensity is 4 or higher on the NRS (Numeric Rating Scale, 0–10), or if it disrupts sleep or makes daily activities difficult. This applies even more when allodynia is present. If contact as light as a shirt collar brushing the skin triggers severe pain, central sensitization may already be underway, and a specialist evaluation becomes necessary.
Older patients, patients with diabetes, and immunosuppressed patients have a relatively higher likelihood of progressing to PHN. For these patients, following the course together with a pain specialist from the time of the shingles diagnosis can help guide the treatment direction going forward (Lim Delwyn Zhi Jie et al., 2025).
Anesthesiology and Pain Medicine (pain medicine) is the specialty that directly performs nerve blocks and interventional nerve procedures. In situations that call for options beyond medication alone — that is, when the response to medication is insufficient or side effects make it difficult to raise the dose — seeing a pain medicine specialist can help broaden the available treatment options. Its role is to assess the extent of nerve damage and set out a staged procedural plan.
Clinically, in cases where central sensitization becomes fixed because early intervention didn't happen after the blisters resolved, treatment takes longer. Once central sensitization has set in, treatment requires more time and more attempts. This is exactly why early evaluation and intervention matter in PHN.
Key Summary
Postherpetic neuralgia is neuropathic pain that persists for three months or more after the blisters have healed. Diagnostic criteria can vary across the literature. The structural cause of the pain is peripheral and central sensitization, which begins when the virus damages the dorsal root ganglia of the spinal cord — and this is why the pain differs fundamentally in character from ordinary wound pain.
Treatment starts with medications (gabapentinoids, tricyclic antidepressants, lidocaine patches) and, if the response is insufficient, moves in stages to interventional procedures such as nerve blocks. The goal at each stage goes beyond temporarily reducing pain — it is to regulate distorted nerve signals and create conditions that allow the nerve to recover. Treatment response can vary from person to person.
If pain remains four weeks or more after the blisters clear, if pain of NRS 4 or higher disrupts sleep and daily life, or if allodynia develops, this is a point at which seeing a pain medicine specialist may be worth considering. For elderly patients or those with diabetes or compromised immunity, tracking the clinical course together with a specialist from the early stage of a herpes zoster diagnosis may help reduce the risk of the condition becoming chronic.
Early intervention is an important factor that may help reduce the risk of chronicity. The longer a patient waits in the expectation that the pain will resolve on its own, the more firmly the pain circuitry within the nervous system may become entrenched.
This content is provided for medical information purposes and may vary depending on individual conditions. Please consult a specialist for accurate diagnosis and treatment.
References
- Lim Delwyn Zhi Jie, Tey Hong Liang, Salada Brenda Mae Alferez (2025). Herpes Zoster and Post-Herpetic Neuralgia-Diagnosis, Treatment, and Vaccination Strategies.. Pathogens. PMID: 39057822
- Patil Anant, Goldust Mohamad, Wollina Uwe (2022). Herpes zoster: A Review of Clinical Manifestations and Management.. Viruses. PMID: 35215786
- Finnerup Nanna Brix, Kuner Rohini, Jensen Troels Staehelin (2021). Neuropathic Pain: From Mechanisms to Treatment.. Physiol Rev. PMID: 32584191
Frequently Asked Questions
If pain persists in the same area 90 days (three months) after the blisters clear, it is diagnosed as PHN. However, since the risk of chronicity already rises once pain has lasted more than four weeks, seeking specialist care early, rather than waiting the full three months, is more favorable for the course of the condition.
In some patients, pain gradually decreases over several months. However, when central sensitization has deepened, natural improvement without treatment is unlikely, and the longer the condition goes untreated, the lower the likelihood of nerve recovery tends to be. If the pain is severe enough to interfere with sleep or daily activities, waiting for it to resolve on its own is not recommended.
When a patient does not respond adequately to first-line drug treatments such as gabapentinoids or tricyclic antidepressants, or when side effects make it difficult to increase the dose, nerve block procedures are considered as a stepwise option. By acting directly on the damaged nerve pathway to block distorted pain signals, this approach plays a complementary role for pain that cannot be controlled by medication alone.
Advanced age and diabetes are known risk factors for progression to PHN. Age-related decline in immune function can make virus-induced nerve damage more extensive, and because diabetes already leaves peripheral nerves in a vulnerable state, sensitization can progress rapidly. Patients with these underlying conditions need more active monitoring from the early stage of shingles onset.
Patients with PHN can receive stepwise treatment—including drug therapy and interventional nerve procedures—at pain medicine clinics (Department of Anesthesiology and Pain Medicine) that specialize in neuropathic pain. Even if initial shingles treatment was received at a dermatology or internal medicine clinic, referral to a pain medicine specialist is appropriate if pain persists after the blisters clear.